Article
Field evaluation of GeneXpert® (Cepheid) HCV performance for RNA quantification in a genotype 1 and 6 predominant patient population in Cambodia.
Journal of viral hepatitis - 1 Jan 2019
Iwamoto Momoko, Calzia Aurelie, Dublineau Amelie, Rouet François, Nouhin Janin, Yann Sokchea, Pin Sophorn, Sun Chhorvy, Sann Kimchamroeun, Dimanche Chhit, Lastrucci Celine, Coulborn Rebecca M, Maman David, Dousset Jean-Philippe, Loarec Anne
Abstract excerpt
GeneXpert® (Cepheid) is the only WHO prequalified platform for hepatitis C virus (HCV) nucleic acid amplification testing that is suitable for point-of-care use in resource-limited contexts. However, its application is constrained by the lack of evidence on genotype 6 (GT6) HCV. We evaluated its field performance among a patient population in Cambodia predominantly infected with GT6. Between August and September...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
